Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EG017 for stress urinary incontinence in postmenopausal women
CTR20231942Phase 2Terminated
- Sponsor
- Ningbo Xijian Medical Science & Technology
- Start
- Jun 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EG-017 in stress urinary incontinence (SUI), sponsored by Ningbo Xijian Medical Science & Technology. Started Jun 2023; status: terminated.
02
Drugs
EG-017
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on CTR20231942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231942.